| Stereotactic body radiation therapy: the report of AAPM Task Group 101 | Medical Physics | 2010 | 1.2K |
| Advanced pancreatic carcinoma: current treatment and future challenges | Nature Reviews Clinical Oncology | 2010 | 603 |
| Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference | Annals of Oncology | 2010 | 502 |
| Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL) | Annals of Oncology | 2010 | 485 |
| Radiation-associated liver injury | International Journal of Radiation Oncology Biology Physics | 2010 | 467 |
| Gold nanoparticles as radiation sensitizers in cancer therapy | Radiation Research | 2010 | 436 |
| Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial | Journal of Clinical Oncology | 2010 | 424 |
| Radiation dose-volume effects in the stomach and small bowel | International Journal of Radiation Oncology Biology Physics | 2010 | 382 |
| Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection | Clinical Infectious Diseases | 2010 | 336 |
| Assessing women at high risk of breast cancer: a review of risk assessment models | Journal of the National Cancer Institute | 2010 | 334 |
| Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas | Clinical Cancer Research | 2010 | 317 |
| Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure | Journal of Clinical Oncology | 2010 | 312 |
| Results of a multi-institution deformable registration accuracy study (MIDRAS) | International Journal of Radiation Oncology Biology Physics | 2010 | 300 |
| Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10 | Journal of Clinical Oncology | 2010 | 279 |
| The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles | Molecular Pharmaceutics | 2010 | 275 |
| Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study | Journal of Clinical Oncology | 2010 | 271 |
| Defining the risks of mesenchymal stromal cell therapy | Cytotherapy | 2010 | 249 |
| Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features | Radiology | 2010 | 220 |
| Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America | Cancer | 2010 | 219 |
| Outcome of transplantation for myelofibrosis | Biology of Blood and Marrow Transplantation | 2010 | 206 |
| Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity | Diabetes | 2010 | 200 |
| Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease | Journal of Psychosomatic Research | 2010 | 200 |
| Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer | Journal of Clinical Oncology | 2010 | 195 |
| Radiation-associated kidney injury | International Journal of Radiation Oncology Biology Physics | 2010 | 189 |
| Nasopharyngeal carcinoma: the next challenges | European Journal of Cancer | 2010 | 181 |
